Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kv1.3 Potassium Channel | 30 | 2023 | 36 | 4.560 |
Why?
|
Potassium Channel Blockers | 27 | 2023 | 110 | 3.680 |
Why?
|
Arthritis, Rheumatoid | 12 | 2023 | 410 | 2.250 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 8 | 2019 | 27 | 2.060 |
Why?
|
Autoimmune Diseases | 10 | 2023 | 402 | 1.660 |
Why?
|
Cnidarian Venoms | 9 | 2015 | 10 | 1.550 |
Why?
|
Peptides | 14 | 2023 | 1479 | 1.480 |
Why?
|
Hypersensitivity, Delayed | 9 | 2017 | 104 | 1.430 |
Why?
|
Scorpion Venoms | 9 | 2018 | 15 | 1.430 |
Why?
|
Potassium Channels, Voltage-Gated | 10 | 2007 | 64 | 1.360 |
Why?
|
T-Lymphocytes | 26 | 2019 | 3869 | 1.250 |
Why?
|
Ion Channels | 5 | 2018 | 212 | 1.220 |
Why?
|
Immunologic Memory | 13 | 2020 | 374 | 1.190 |
Why?
|
Rats | 32 | 2023 | 6086 | 1.160 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 9 | 2012 | 96 | 1.100 |
Why?
|
Dependovirus | 2 | 2023 | 135 | 1.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2017 | 568 | 0.920 |
Why?
|
Matrix Metalloproteinases | 2 | 2017 | 143 | 0.920 |
Why?
|
Sea Anemones | 4 | 2015 | 5 | 0.760 |
Why?
|
Rats, Inbred Lew | 16 | 2019 | 113 | 0.750 |
Why?
|
Probiotics | 1 | 2023 | 228 | 0.720 |
Why?
|
Intermediate-Conductance Calcium-Activated Potassium Channels | 5 | 2013 | 13 | 0.600 |
Why?
|
Animals | 56 | 2023 | 59536 | 0.600 |
Why?
|
Myoblasts, Skeletal | 1 | 2016 | 18 | 0.590 |
Why?
|
Cell Separation | 3 | 2007 | 612 | 0.550 |
Why?
|
Antirheumatic Agents | 1 | 2017 | 167 | 0.540 |
Why?
|
Killer Cells, Natural | 2 | 2013 | 904 | 0.530 |
Why?
|
Synoviocytes | 4 | 2019 | 4 | 0.510 |
Why?
|
Cell Movement | 5 | 2016 | 2466 | 0.510 |
Why?
|
Potassium Channels | 7 | 2004 | 162 | 0.480 |
Why?
|
Spinal Cord | 2 | 2007 | 690 | 0.470 |
Why?
|
Multiple Sclerosis | 6 | 2011 | 349 | 0.470 |
Why?
|
Polyethylene Glycols | 1 | 2017 | 615 | 0.460 |
Why?
|
Th2 Cells | 1 | 2014 | 257 | 0.440 |
Why?
|
Models, Molecular | 9 | 2015 | 1732 | 0.410 |
Why?
|
Fibroblasts | 7 | 2022 | 1682 | 0.410 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2013 | 675 | 0.400 |
Why?
|
Disease Models, Animal | 10 | 2018 | 7222 | 0.390 |
Why?
|
Glucose Transporter Type 4 | 1 | 2010 | 26 | 0.390 |
Why?
|
Spleen | 2 | 2017 | 676 | 0.390 |
Why?
|
Cells, Cultured | 11 | 2019 | 5637 | 0.390 |
Why?
|
Ovalbumin | 5 | 2017 | 254 | 0.380 |
Why?
|
Flow Cytometry | 5 | 2016 | 3033 | 0.380 |
Why?
|
T-Lymphocyte Subsets | 3 | 2020 | 582 | 0.370 |
Why?
|
Synovial Membrane | 3 | 2015 | 41 | 0.360 |
Why?
|
Arthritis, Experimental | 3 | 2019 | 47 | 0.350 |
Why?
|
Patch-Clamp Techniques | 8 | 2018 | 388 | 0.350 |
Why?
|
Receptors, CCR7 | 7 | 2014 | 39 | 0.340 |
Why?
|
Adjuvants, Immunologic | 3 | 2007 | 657 | 0.320 |
Why?
|
Protein Conformation | 9 | 2015 | 1258 | 0.320 |
Why?
|
Ion Channel Gating | 4 | 2013 | 141 | 0.320 |
Why?
|
Cell Line | 13 | 2017 | 5114 | 0.310 |
Why?
|
Kv1.1 Potassium Channel | 5 | 2015 | 39 | 0.310 |
Why?
|
Hemocyanins | 1 | 2007 | 50 | 0.310 |
Why?
|
Freund's Adjuvant | 1 | 2007 | 43 | 0.310 |
Why?
|
Biomedical Technology | 1 | 2007 | 35 | 0.300 |
Why?
|
Punctures | 1 | 2007 | 104 | 0.300 |
Why?
|
Interleukin-2 | 3 | 2007 | 842 | 0.300 |
Why?
|
Saphenous Vein | 1 | 2007 | 95 | 0.290 |
Why?
|
Blood Specimen Collection | 1 | 2007 | 93 | 0.290 |
Why?
|
Mice | 23 | 2023 | 34495 | 0.280 |
Why?
|
Cell Differentiation | 2 | 2016 | 4078 | 0.280 |
Why?
|
Clinical Laboratory Techniques | 1 | 2007 | 203 | 0.280 |
Why?
|
Lymphocyte Activation | 9 | 2014 | 1688 | 0.270 |
Why?
|
Asthma | 1 | 2014 | 871 | 0.270 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 5159 | 0.270 |
Why?
|
Cell Membrane | 3 | 2016 | 850 | 0.260 |
Why?
|
Amino Acid Sequence | 8 | 2015 | 4233 | 0.260 |
Why?
|
Potassium Channels, Calcium-Activated | 1 | 2004 | 13 | 0.260 |
Why?
|
Matrix Metalloproteinase 2 | 3 | 2016 | 256 | 0.250 |
Why?
|
Cell Division | 3 | 2007 | 2489 | 0.250 |
Why?
|
Calcium | 8 | 2018 | 1537 | 0.250 |
Why?
|
Calcium Channels | 3 | 2015 | 197 | 0.240 |
Why?
|
Demyelinating Diseases | 1 | 2004 | 77 | 0.240 |
Why?
|
Toxins, Biological | 2 | 2015 | 51 | 0.240 |
Why?
|
Monocytes | 1 | 2007 | 788 | 0.230 |
Why?
|
Fluoresceins | 1 | 2003 | 73 | 0.220 |
Why?
|
Electrophysiology | 5 | 2014 | 333 | 0.220 |
Why?
|
Neurotoxins | 3 | 2015 | 66 | 0.220 |
Why?
|
Cell Adhesion | 2 | 2017 | 1008 | 0.220 |
Why?
|
Up-Regulation | 2 | 2013 | 2450 | 0.220 |
Why?
|
Terpenes | 3 | 2017 | 34 | 0.210 |
Why?
|
Molecular Sequence Data | 6 | 2015 | 6089 | 0.210 |
Why?
|
Syndecan-2 | 1 | 2022 | 15 | 0.210 |
Why?
|
Fluorescent Dyes | 2 | 2008 | 459 | 0.200 |
Why?
|
Humans | 40 | 2023 | 261506 | 0.200 |
Why?
|
TRPV Cation Channels | 2 | 2015 | 76 | 0.200 |
Why?
|
Receptors, Chemokine | 3 | 2013 | 114 | 0.200 |
Why?
|
Pancreatitis-Associated Proteins | 2 | 2013 | 32 | 0.190 |
Why?
|
Immunity, Innate | 2 | 2016 | 677 | 0.190 |
Why?
|
Heart | 1 | 2007 | 1223 | 0.190 |
Why?
|
Pulmonary Fibrosis | 1 | 2022 | 170 | 0.190 |
Why?
|
Lung Injury | 1 | 2022 | 131 | 0.190 |
Why?
|
Inhibitory Concentration 50 | 3 | 2015 | 289 | 0.180 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2015 | 4938 | 0.180 |
Why?
|
Nonsense Mediated mRNA Decay | 1 | 2019 | 38 | 0.180 |
Why?
|
Recombinant Proteins | 3 | 2015 | 2927 | 0.170 |
Why?
|
Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 83 | 0.170 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2006 | 830 | 0.170 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2018 | 50 | 0.160 |
Why?
|
Mutation | 1 | 2018 | 15179 | 0.150 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 112 | 0.150 |
Why?
|
Gene Editing | 1 | 2020 | 216 | 0.150 |
Why?
|
Emulsions | 2 | 2007 | 82 | 0.150 |
Why?
|
Testicular Diseases | 1 | 2016 | 22 | 0.150 |
Why?
|
Arthritis | 2 | 2015 | 139 | 0.150 |
Why?
|
Brain | 2 | 2007 | 4113 | 0.140 |
Why?
|
Interleukin-10 | 2 | 2023 | 478 | 0.140 |
Why?
|
Cell Fusion | 1 | 2016 | 80 | 0.140 |
Why?
|
Intracellular Space | 1 | 2016 | 77 | 0.140 |
Why?
|
Integrin beta1 | 1 | 2017 | 126 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 2 | 2017 | 709 | 0.140 |
Why?
|
Phenotype | 5 | 2018 | 6295 | 0.140 |
Why?
|
Cell Proliferation | 8 | 2016 | 7226 | 0.140 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2015 | 548 | 0.140 |
Why?
|
Immunosuppressive Agents | 3 | 2012 | 1375 | 0.140 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2016 | 116 | 0.140 |
Why?
|
Memory | 1 | 2019 | 429 | 0.140 |
Why?
|
Learning | 1 | 2019 | 403 | 0.140 |
Why?
|
Proteins | 3 | 2014 | 1963 | 0.140 |
Why?
|
Antigens | 3 | 2007 | 292 | 0.140 |
Why?
|
Magnetic Resonance Spectroscopy | 4 | 2014 | 624 | 0.140 |
Why?
|
Immunomodulation | 1 | 2017 | 242 | 0.130 |
Why?
|
Kinetics | 3 | 2015 | 2049 | 0.130 |
Why?
|
Chromatography, Reverse-Phase | 1 | 2015 | 5 | 0.130 |
Why?
|
Myelin Basic Protein | 3 | 2004 | 85 | 0.130 |
Why?
|
Allergens | 1 | 2017 | 247 | 0.130 |
Why?
|
Cystic Fibrosis | 1 | 2018 | 264 | 0.130 |
Why?
|
Myotonic Dystrophy | 1 | 2016 | 151 | 0.130 |
Why?
|
Disulfides | 2 | 2005 | 116 | 0.130 |
Why?
|
Calcium Signaling | 2 | 2014 | 284 | 0.130 |
Why?
|
Adoptive Transfer | 3 | 2007 | 446 | 0.130 |
Why?
|
Genetic Vectors | 1 | 2020 | 1694 | 0.120 |
Why?
|
Antibody Formation | 1 | 2015 | 383 | 0.120 |
Why?
|
Peptide Fragments | 3 | 2015 | 1271 | 0.120 |
Why?
|
Gastrointestinal Microbiome | 1 | 2023 | 907 | 0.120 |
Why?
|
Protein Stability | 2 | 2014 | 370 | 0.120 |
Why?
|
Injections, Subcutaneous | 3 | 2017 | 334 | 0.120 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channels | 1 | 2014 | 32 | 0.120 |
Why?
|
Mutant Proteins | 1 | 2015 | 234 | 0.120 |
Why?
|
Interleukin-5 | 1 | 2014 | 73 | 0.120 |
Why?
|
Rats, Inbred F344 | 1 | 2014 | 224 | 0.120 |
Why?
|
Protein Engineering | 2 | 2011 | 100 | 0.120 |
Why?
|
Helminths | 1 | 2014 | 37 | 0.120 |
Why?
|
CX3C Chemokine Receptor 1 | 1 | 2013 | 23 | 0.120 |
Why?
|
Inflammation | 2 | 2023 | 2522 | 0.120 |
Why?
|
Cell Degranulation | 1 | 2013 | 47 | 0.120 |
Why?
|
Interleukin-13 | 1 | 2014 | 135 | 0.120 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 984 | 0.120 |
Why?
|
Neural Conduction | 2 | 2004 | 112 | 0.120 |
Why?
|
Antibodies, Bacterial | 1 | 2015 | 380 | 0.120 |
Why?
|
Interleukin-4 | 1 | 2014 | 284 | 0.110 |
Why?
|
Spinal Cord Injuries | 1 | 2016 | 374 | 0.110 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2014 | 254 | 0.110 |
Why?
|
Antioxidants | 1 | 2016 | 507 | 0.110 |
Why?
|
Liver | 1 | 2023 | 2961 | 0.110 |
Why?
|
K562 Cells | 1 | 2013 | 338 | 0.110 |
Why?
|
Myocytes, Cardiac | 1 | 2018 | 764 | 0.110 |
Why?
|
Pichia | 1 | 2012 | 60 | 0.110 |
Why?
|
Botulinum Toxins, Type A | 1 | 2015 | 185 | 0.110 |
Why?
|
Drug Design | 1 | 2015 | 375 | 0.110 |
Why?
|
Interleukin-15 | 1 | 2013 | 185 | 0.110 |
Why?
|
Thioredoxins | 1 | 2012 | 50 | 0.110 |
Why?
|
Interleukin-12 | 1 | 2013 | 253 | 0.110 |
Why?
|
Synovial Fluid | 1 | 2011 | 27 | 0.100 |
Why?
|
Gene Expression Regulation | 4 | 2022 | 4053 | 0.100 |
Why?
|
Rheumatic Fever | 1 | 2011 | 18 | 0.100 |
Why?
|
Immunity, Cellular | 1 | 2014 | 419 | 0.100 |
Why?
|
Immune Tolerance | 1 | 2014 | 403 | 0.100 |
Why?
|
Nanoparticles | 1 | 2016 | 554 | 0.100 |
Why?
|
Shaker Superfamily of Potassium Channels | 1 | 2011 | 23 | 0.100 |
Why?
|
Female | 22 | 2019 | 141928 | 0.100 |
Why?
|
Time Factors | 4 | 2007 | 12926 | 0.100 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 521 | 0.100 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 2010 | 22 | 0.100 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 719 | 0.100 |
Why?
|
Acrylic Resins | 1 | 2010 | 43 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 2 | 2015 | 1555 | 0.090 |
Why?
|
Guinea Pigs | 4 | 2003 | 241 | 0.090 |
Why?
|
Obesity | 1 | 2023 | 2884 | 0.090 |
Why?
|
Cytokines | 4 | 2023 | 2809 | 0.090 |
Why?
|
Rats, Wistar | 2 | 2017 | 562 | 0.090 |
Why?
|
Binding, Competitive | 2 | 2012 | 300 | 0.090 |
Why?
|
NF-kappa B | 1 | 2016 | 1549 | 0.090 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2007 | 219 | 0.080 |
Why?
|
Ear, External | 1 | 2008 | 42 | 0.080 |
Why?
|
Shab Potassium Channels | 1 | 2007 | 2 | 0.080 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2008 | 59 | 0.080 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 2007 | 8 | 0.080 |
Why?
|
NAV1.8 Voltage-Gated Sodium Channel | 1 | 2007 | 6 | 0.080 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2007 | 7 | 0.080 |
Why?
|
Computer Simulation | 1 | 2013 | 1529 | 0.080 |
Why?
|
Concanavalin A | 1 | 2007 | 67 | 0.080 |
Why?
|
Mitogens | 1 | 2007 | 75 | 0.080 |
Why?
|
Injections, Intradermal | 1 | 2007 | 58 | 0.080 |
Why?
|
Blood Cells | 1 | 2007 | 127 | 0.080 |
Why?
|
Protein Structure, Secondary | 2 | 2005 | 336 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2330 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2011 | 649 | 0.080 |
Why?
|
Rats, Inbred Strains | 1 | 2007 | 410 | 0.080 |
Why?
|
Antigen-Presenting Cells | 1 | 2008 | 284 | 0.080 |
Why?
|
Sodium Channels | 1 | 2007 | 109 | 0.070 |
Why?
|
Dermatitis | 1 | 2007 | 60 | 0.070 |
Why?
|
Young Adult | 2 | 2017 | 21445 | 0.070 |
Why?
|
Tissue Distribution | 2 | 2012 | 875 | 0.070 |
Why?
|
Calcium Channel Blockers | 2 | 2004 | 135 | 0.070 |
Why?
|
Mice, Knockout | 3 | 2023 | 5710 | 0.070 |
Why?
|
Protein Structure, Tertiary | 2 | 2012 | 1487 | 0.070 |
Why?
|
Pyrazoles | 2 | 2013 | 1471 | 0.070 |
Why?
|
Immunization | 2 | 2020 | 397 | 0.070 |
Why?
|
HEK293 Cells | 3 | 2019 | 1489 | 0.070 |
Why?
|
Optic Nerve | 2 | 2004 | 133 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 3 | 2016 | 2063 | 0.070 |
Why?
|
Structure-Activity Relationship | 3 | 2015 | 931 | 0.070 |
Why?
|
Immunoglobulin Class Switching | 1 | 2005 | 51 | 0.060 |
Why?
|
Kv1.2 Potassium Channel | 1 | 2004 | 16 | 0.060 |
Why?
|
Small-Conductance Calcium-Activated Potassium Channels | 1 | 2004 | 14 | 0.060 |
Why?
|
Static Electricity | 1 | 2004 | 58 | 0.060 |
Why?
|
Synaptosomes | 1 | 2004 | 37 | 0.060 |
Why?
|
Furocoumarins | 1 | 2004 | 9 | 0.060 |
Why?
|
Elapid Venoms | 1 | 2004 | 11 | 0.060 |
Why?
|
Sequence Analysis, Protein | 1 | 2004 | 81 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 5539 | 0.060 |
Why?
|
Action Potentials | 2 | 2004 | 560 | 0.060 |
Why?
|
Autoimmunity | 1 | 2005 | 263 | 0.060 |
Why?
|
Molecular Dynamics Simulation | 2 | 2015 | 131 | 0.060 |
Why?
|
Adult | 6 | 2017 | 77950 | 0.060 |
Why?
|
Myelin Sheath | 1 | 2004 | 149 | 0.060 |
Why?
|
Protein Binding | 3 | 2015 | 3438 | 0.060 |
Why?
|
Biotin | 1 | 2003 | 69 | 0.060 |
Why?
|
Middle Aged | 6 | 2017 | 86204 | 0.050 |
Why?
|
Magnesium | 1 | 2023 | 160 | 0.050 |
Why?
|
Anti-Citrullinated Protein Antibodies | 1 | 2022 | 4 | 0.050 |
Why?
|
RNA Interference | 2 | 2018 | 1408 | 0.050 |
Why?
|
Citrullination | 1 | 2022 | 7 | 0.050 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2022 | 16 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2022 | 2054 | 0.050 |
Why?
|
Chronic Disease | 1 | 2007 | 1819 | 0.050 |
Why?
|
Th17 Cells | 1 | 2023 | 162 | 0.050 |
Why?
|
Lymphocytes | 2 | 2004 | 1234 | 0.050 |
Why?
|
Sp1 Transcription Factor | 1 | 2022 | 188 | 0.050 |
Why?
|
Protein Kinase C | 1 | 2003 | 396 | 0.050 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 2216 | 0.050 |
Why?
|
Immunotherapy | 1 | 2014 | 3341 | 0.050 |
Why?
|
Male | 10 | 2019 | 123000 | 0.050 |
Why?
|
Bleomycin | 1 | 2022 | 467 | 0.050 |
Why?
|
COS Cells | 2 | 2012 | 377 | 0.050 |
Why?
|
Gene Order | 1 | 2020 | 111 | 0.050 |
Why?
|
Gene Expression | 2 | 2020 | 3570 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2003 | 1033 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 7702 | 0.050 |
Why?
|
Scorpions | 2 | 2012 | 5 | 0.040 |
Why?
|
Animals, Newborn | 1 | 2004 | 1338 | 0.040 |
Why?
|
Amino Acids | 1 | 2003 | 728 | 0.040 |
Why?
|
Binding Sites | 2 | 2015 | 2171 | 0.040 |
Why?
|
Indenes | 1 | 2018 | 11 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 673 | 0.040 |
Why?
|
Collagen | 2 | 2015 | 752 | 0.040 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 778 | 0.040 |
Why?
|
Hypertrophy | 1 | 2018 | 162 | 0.040 |
Why?
|
Furans | 1 | 2018 | 104 | 0.040 |
Why?
|
Language Development Disorders | 1 | 2019 | 167 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 3203 | 0.040 |
Why?
|
Transgenes | 1 | 2020 | 557 | 0.040 |
Why?
|
Sarcoplasmic Reticulum | 1 | 2018 | 191 | 0.040 |
Why?
|
Hepatocytes | 1 | 2020 | 351 | 0.040 |
Why?
|
Sulfones | 1 | 2018 | 143 | 0.040 |
Why?
|
Neoplasms | 2 | 2014 | 15193 | 0.040 |
Why?
|
Heterocyclic Compounds, 4 or More Rings | 1 | 2018 | 119 | 0.040 |
Why?
|
Isotope Labeling | 2 | 2012 | 142 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2003 | 1620 | 0.040 |
Why?
|
Arteries | 1 | 2018 | 274 | 0.040 |
Why?
|
Nanoconjugates | 1 | 2016 | 5 | 0.040 |
Why?
|
Dogs | 1 | 2018 | 1155 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2007 | 4320 | 0.040 |
Why?
|
Inflammasomes | 1 | 2018 | 161 | 0.040 |
Why?
|
Nanocapsules | 1 | 2016 | 28 | 0.040 |
Why?
|
Cell Tracking | 1 | 2016 | 38 | 0.040 |
Why?
|
Administration, Intravenous | 1 | 2017 | 249 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2016 | 172 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1681 | 0.030 |
Why?
|
Aging | 1 | 2004 | 1582 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 1678 | 0.030 |
Why?
|
Tissue Culture Techniques | 1 | 2015 | 114 | 0.030 |
Why?
|
Cannabinoids | 1 | 2015 | 38 | 0.030 |
Why?
|
Cannabidiol | 1 | 2015 | 42 | 0.030 |
Why?
|
Drosophila | 1 | 2019 | 839 | 0.030 |
Why?
|
Electroencephalography | 1 | 2018 | 898 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2022 | 4143 | 0.030 |
Why?
|
Thermodynamics | 1 | 2013 | 196 | 0.030 |
Why?
|
Protein Subunits | 1 | 2014 | 274 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1077 | 0.030 |
Why?
|
Metabolomics | 1 | 2016 | 478 | 0.030 |
Why?
|
Oligopeptides | 1 | 2015 | 429 | 0.030 |
Why?
|
Isoenzymes | 1 | 2015 | 614 | 0.030 |
Why?
|
Absorption | 1 | 2012 | 81 | 0.030 |
Why?
|
Nitrogen Isotopes | 1 | 2012 | 60 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2014 | 997 | 0.030 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2012 | 71 | 0.030 |
Why?
|
Chromatography, Affinity | 1 | 2012 | 122 | 0.030 |
Why?
|
Amides | 1 | 2012 | 123 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2012 | 137 | 0.030 |
Why?
|
Enzyme Precursors | 1 | 2011 | 66 | 0.030 |
Why?
|
Gelatinases | 1 | 2011 | 52 | 0.030 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2012 | 105 | 0.030 |
Why?
|
Saimiri | 1 | 2012 | 113 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2014 | 842 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2013 | 644 | 0.030 |
Why?
|
Phylogeny | 1 | 2014 | 826 | 0.030 |
Why?
|
In Vitro Techniques | 2 | 2005 | 1618 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 987 | 0.030 |
Why?
|
Protein Folding | 1 | 2012 | 281 | 0.020 |
Why?
|
Receptors, Interleukin-7 | 1 | 2011 | 44 | 0.020 |
Why?
|
Cholecalciferol | 1 | 2011 | 46 | 0.020 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2011 | 46 | 0.020 |
Why?
|
Sunlight | 1 | 2011 | 79 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2016 | 6150 | 0.020 |
Why?
|
Lung | 1 | 2022 | 3151 | 0.020 |
Why?
|
Receptors, Interleukin-2 | 1 | 2011 | 186 | 0.020 |
Why?
|
Glycosylation | 1 | 2011 | 213 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2011 | 521 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 3536 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 1399 | 0.020 |
Why?
|
Sulfonamides | 1 | 2018 | 1823 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2011 | 519 | 0.020 |
Why?
|
Vaccination | 1 | 2015 | 1123 | 0.020 |
Why?
|
Indoles | 1 | 2015 | 1009 | 0.020 |
Why?
|
Xanthenes | 1 | 2008 | 8 | 0.020 |
Why?
|
Chlamydia trachomatis | 1 | 2008 | 30 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2014 | 697 | 0.020 |
Why?
|
Orthomyxoviridae | 1 | 2008 | 94 | 0.020 |
Why?
|
Chlamydia Infections | 1 | 2008 | 51 | 0.020 |
Why?
|
Biomarkers | 1 | 2020 | 5047 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2011 | 6100 | 0.020 |
Why?
|
Orthomyxoviridae Infections | 1 | 2008 | 72 | 0.020 |
Why?
|
Haplotypes | 1 | 2011 | 856 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2013 | 1152 | 0.020 |
Why?
|
Signal Transduction | 2 | 2018 | 11965 | 0.020 |
Why?
|
CTLA-4 Antigen | 1 | 2011 | 657 | 0.020 |
Why?
|
Homeostasis | 1 | 2011 | 950 | 0.020 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2011 | 598 | 0.020 |
Why?
|
Escherichia coli | 1 | 2012 | 1203 | 0.020 |
Why?
|
Antigens, CD | 1 | 2011 | 1385 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 6942 | 0.020 |
Why?
|
Down-Regulation | 1 | 2011 | 2074 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2011 | 1533 | 0.020 |
Why?
|
Immunoconjugates | 1 | 2008 | 279 | 0.020 |
Why?
|
Cnidaria | 1 | 2003 | 2 | 0.010 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2003 | 60 | 0.010 |
Why?
|
Skin | 1 | 2008 | 1259 | 0.010 |
Why?
|
CD3 Complex | 1 | 2003 | 314 | 0.010 |
Why?
|
Genetic Variation | 1 | 2011 | 2086 | 0.010 |
Why?
|
Tritium | 1 | 2001 | 200 | 0.010 |
Why?
|
Thymidine | 1 | 2001 | 155 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 2001 | 45 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 3890 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 769 | 0.010 |
Why?
|
Jurkat Cells | 1 | 2001 | 311 | 0.010 |
Why?
|
Aged | 2 | 2016 | 70117 | 0.010 |
Why?
|
Child | 1 | 2019 | 29154 | 0.010 |
Why?
|
Cohort Studies | 1 | 2011 | 9244 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2008 | 2967 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 14551 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2003 | 1586 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2001 | 1538 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 7548 | 0.010 |
Why?
|
Risk Factors | 1 | 2011 | 17523 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2011 | 29902 | 0.010 |
Why?
|